Lia A Parkin, Kindra L Becker, Julian P Maceren, Aseem Palande, Neetika Jaisinghani, Mary L Previti, Jessica C Seeliger
{"title":"代谢标记揭示分枝杆菌表面相关脂蛋白。","authors":"Lia A Parkin, Kindra L Becker, Julian P Maceren, Aseem Palande, Neetika Jaisinghani, Mary L Previti, Jessica C Seeliger","doi":"10.1021/acsinfecdis.5c00365","DOIUrl":null,"url":null,"abstract":"<p><p>Mycobacteria such as the causative agent of tuberculosis, <i>Mycobacterium tuberculosis</i> (<i>Mtb</i>), encode over 100 bioinformatically predicted lipoproteins. Despite the importance of these post-translationally modified proteins for mycobacterial survival, many remain experimentally unconfirmed. Here we characterized in <i>Mtb</i> and <i>M. smegmatis</i> (<i>Msm</i>) the metabolic incorporation of several modified fatty acids as a facile method of adding chemical groups that enable downstream applications such as detection and enrichment of lipid-modified proteins. We further showed for azido palmitic acid in <i>Msm</i> that incorporation is an active process dependent on the lipoprotein biosynthesis pathway and that a subset of these lipid-modified proteins are associated with the mycobacterial cell surface. Because mycobacteria do not encode known lipoprotein transporters, these data have implications for uncovering the roles of lipoproteins and the possible transport processes involved. Our findings and the tools we validated will enable the further study of pathways related to lipoprotein function in mycobacteria and other bacteria in which lipoproteins remain poorly understood.</p>","PeriodicalId":17,"journal":{"name":"ACS Infectious Diseases","volume":" ","pages":""},"PeriodicalIF":3.8000,"publicationDate":"2025-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Metabolic Tagging Reveals Surface-Associated Lipoproteins in Mycobacteria.\",\"authors\":\"Lia A Parkin, Kindra L Becker, Julian P Maceren, Aseem Palande, Neetika Jaisinghani, Mary L Previti, Jessica C Seeliger\",\"doi\":\"10.1021/acsinfecdis.5c00365\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Mycobacteria such as the causative agent of tuberculosis, <i>Mycobacterium tuberculosis</i> (<i>Mtb</i>), encode over 100 bioinformatically predicted lipoproteins. Despite the importance of these post-translationally modified proteins for mycobacterial survival, many remain experimentally unconfirmed. Here we characterized in <i>Mtb</i> and <i>M. smegmatis</i> (<i>Msm</i>) the metabolic incorporation of several modified fatty acids as a facile method of adding chemical groups that enable downstream applications such as detection and enrichment of lipid-modified proteins. We further showed for azido palmitic acid in <i>Msm</i> that incorporation is an active process dependent on the lipoprotein biosynthesis pathway and that a subset of these lipid-modified proteins are associated with the mycobacterial cell surface. Because mycobacteria do not encode known lipoprotein transporters, these data have implications for uncovering the roles of lipoproteins and the possible transport processes involved. Our findings and the tools we validated will enable the further study of pathways related to lipoprotein function in mycobacteria and other bacteria in which lipoproteins remain poorly understood.</p>\",\"PeriodicalId\":17,\"journal\":{\"name\":\"ACS Infectious Diseases\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":3.8000,\"publicationDate\":\"2025-09-12\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"ACS Infectious Diseases\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1021/acsinfecdis.5c00365\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"CHEMISTRY, MEDICINAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Infectious Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1021/acsinfecdis.5c00365","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
Metabolic Tagging Reveals Surface-Associated Lipoproteins in Mycobacteria.
Mycobacteria such as the causative agent of tuberculosis, Mycobacterium tuberculosis (Mtb), encode over 100 bioinformatically predicted lipoproteins. Despite the importance of these post-translationally modified proteins for mycobacterial survival, many remain experimentally unconfirmed. Here we characterized in Mtb and M. smegmatis (Msm) the metabolic incorporation of several modified fatty acids as a facile method of adding chemical groups that enable downstream applications such as detection and enrichment of lipid-modified proteins. We further showed for azido palmitic acid in Msm that incorporation is an active process dependent on the lipoprotein biosynthesis pathway and that a subset of these lipid-modified proteins are associated with the mycobacterial cell surface. Because mycobacteria do not encode known lipoprotein transporters, these data have implications for uncovering the roles of lipoproteins and the possible transport processes involved. Our findings and the tools we validated will enable the further study of pathways related to lipoprotein function in mycobacteria and other bacteria in which lipoproteins remain poorly understood.
期刊介绍:
ACS Infectious Diseases will be the first journal to highlight chemistry and its role in this multidisciplinary and collaborative research area. The journal will cover a diverse array of topics including, but not limited to:
* Discovery and development of new antimicrobial agents — identified through target- or phenotypic-based approaches as well as compounds that induce synergy with antimicrobials.
* Characterization and validation of drug target or pathways — use of single target and genome-wide knockdown and knockouts, biochemical studies, structural biology, new technologies to facilitate characterization and prioritization of potential drug targets.
* Mechanism of drug resistance — fundamental research that advances our understanding of resistance; strategies to prevent resistance.
* Mechanisms of action — use of genetic, metabolomic, and activity- and affinity-based protein profiling to elucidate the mechanism of action of clinical and experimental antimicrobial agents.
* Host-pathogen interactions — tools for studying host-pathogen interactions, cellular biochemistry of hosts and pathogens, and molecular interactions of pathogens with host microbiota.
* Small molecule vaccine adjuvants for infectious disease.
* Viral and bacterial biochemistry and molecular biology.